Learn more about investing in BioROSA Technologies Inc.

Our team will get back to you soon to follow up on your inquiry.
Opt-In Checkbox
We don’t spam. Our Privacy Policy and Cookie Policy apply. The site is protected by reCAPTCHA.
BioROSA Technologies Inc.
Creating a biologically-based diagnostic standard of care for autism spectrum disorders
Founded
2017
Employees*
2-10
Funding to Date*
undisclosed
Website
biorosa.com
* Data source: Crunchbase
John Slattery, CEO
"There is no simple blood test to detect early and intervene when behavioral treatments are most effective."
Autism behavioral diagnosis and treatment is covered by insurance in all 50 states

Over 30 million children and over 100 million people around the world live with autism spectrum disorders (ASD). BioROSA is challenging the status quo by developing cost-effective, fast, and simple diagnostic tools to allow clinicians to easily determine who is at risk for ASD, simplify the diagnostic process, and enable therapeutic developments. We do this through powerful blood-based biomarkers and machine learning tools.